Medical News

DiCE Supports Act4Biosimilars to Increase Patient Access to Biologic Medicines

On 30 January, the Act4Biosimilars initiative hosted a virtual meeting with key stakeholders from across the healthcare space to discuss the Action...

Read

First Immunotherapy Drug Durvalumab Plus Chemotherapy Approved in Europe for Advanced Biliary Cancer

On 21 December the European Commission (EC) approved the use of durvalumab (Imfinzi ®) plus chemotherapy (gemcitabine plus cisplatin) as the first...

Read

The EC Approves Nivolumab Plus Chemotherapy as First Line Treatment for Oesophageal Cancer
Trastuzumab Deruxtecan Approved as Second-line Treatment in Europe For Patients With HER2-positive Advanced Gastric Cancer

On December 19th the European Commission (EC) approved the use of trastuzumab deruxtecan (Enhertu ®) plus chemotherapy (gemcitabine plus cisplatin...

Read

COVID-19 impact on healthcare management of people with chronic diseases

The European Patients’ Forum (EPF) conducted a COVID-19 survey between 18 September to 18 October 2020 (the report is available here).&...

Read

Scientific Update – Study Delivers Promising Results for Genetic Biomarker Test for Stage II Colorectal Cancer cover
Study Delivers Promising Results for Genetic Biomarker Test for Stage II Colorectal Cancer

Sceintific Update – researchers conduct trial to assess if a ctDNA-guided approach could reduce the use of adjuvant chemotherapy in a patient...

Read

Scientists Discover Cell Population Linked to Post Chemotherapy Colon Cancer Recurrence cover
Scientists Discover Cell Population Linked to Post Chemotherapy Colon Cancer Recurrence

Scientific Update: scientists discover cell population linked to post chemotherapy colon cancer recurrence

...

Read

Promising New Findings Published for an Immune Therapy in Certain Type of Rectal Cancer cover
Promising New Findings Published for an Immune Therapy in Certain Type of Rectal Cancer

Promising study results shown for immunology treatment of a certain type of rectal cancer

...

Read

Promising Research Published for Early Detection of a Certain Pancreatic Cancer
Promising Research Published for Early Detection of a Certain Pancreatic Cancer

Study published in ‘Gut’ finds new molecular signature that could help in identifying most common form of pancreatic cancer – PDA...

Read

EMA recommends approval for nivolumab (Opdivo) plus ipilimumab (Yervoy) as a first-line treatment for adults with advanced oesophageal squamous cell carcinoma (OSCC) with PD-L1 expression
EMA approves two combination-treatments for an aggressive oesophageal cancer

EMA recommends approval for nivolumab (Opdivo) plus ipilimumab (Yervoy) as a first-line treatment for adults with advanced oesophageal squamous cel...

Read

Study Shows - DNA Test Prior to Chemotherapy Can Prevent Serious Side Effects for Colorectal Cancer Patients
Study Shows – DNA Test Prior to Chemotherapy Can Prevent Serious Side Effects for Some Colorectal Cancer Patients

Study Shows – DNA Test Prior to Chemotherapy Can Prevent Serious Side Effects for Colorectal Cancer Patients

...

Read

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.